Lactic Acid Bacteria as Delivery Vehicle for Therapeutics Applications

Methods Mol Biol. 2021:2183:447-459. doi: 10.1007/978-1-0716-0795-4_24.

Abstract

Lactic acid bacteria comprise a large group of Gram-positive organisms capable of converting sugar into lactic acid. They have been studied due to their therapeutic potential on the mucosal surface. Among the species, Lactococcus lactis is considered the model bacterium and it has been explored as an important vehicle for providing therapeutic molecules and antigens in the mucosa. They can be genetically engineered to produce a variety of molecules as well as deliver heterologous DNA and protein. DNA vaccines consist of the administration of a bacterial plasmid under the control of a eukaryotic promoter encoding the antigen of interest. The resulting proteins are capable of stimulating the immune system, becoming a promising technique for immunization against a variety of tumors and infection diseases and having several advantages compared to conventional nucleic acid delivery methods (such as bioballistic delivery, electroporation, and intramuscular administration).

Keywords: DNA delivery; DNA vaccine; Lactic acid bacteria; Lactococcus lactis; Mucosal administration.

MeSH terms

  • Administration, Intranasal
  • Administration, Sublingual
  • Animals
  • Drug Delivery Systems*
  • Gene Transfer Techniques*
  • Lactobacillales*
  • Mice
  • Mucous Membrane / immunology
  • Vaccination / methods*
  • Vaccines, DNA / administration & dosage*
  • Vaccines, DNA / genetics
  • Vaccines, DNA / immunology

Substances

  • Vaccines, DNA